Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-003122

CHIEF OPERATING OFFICER sold 4,875 shares at $15.11 ($73,658)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · CHIEF OPERATING OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-06 Sale : show line 1 in the form 10b5-1 −4,875 $15.11 $73,658 12,347 D
Open-market sales · 4,875 sh · avg $15.11 · $73,658
Loading xslF345X05/form4-02092024_010243.xml…